People | January 19, 2022
Sauri Gudlavalleti is the new Chief Operating Officer of Sai Life Sciences
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer
The company's discovery services support a wide range of global innovator companies from start-ups to large pharma companies, across a diverse set of therapeutic areas including oncology, CNS, antivirals, and inflammation among others
Sputnik V is a two-dose shot and has an efficacy of 91.6% against COVID 19
Subscribe To Our Newsletter & Stay Updated
